Idorsia has published the Notice of the Annual General Meeting 2020
It's less than three
years since we launched
with big ambitions.
See how we are getting on...
There’s more to Idorsia
than meets the eye!
Read the interview with
our CEO & CSO to get to
the bottom of the story...
Our key assets have
the potential to
transform treatment in
the target indications...
Idorsia today
The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients.
Idorsia People
Idorsia’s success depends on its people.
Target diseases
Idorsia's development compounds target a number of different diseases.
News
| 02 Apr 2020 | |
| 19 Mar 2020 | |
| 04 Mar 2020 |
Events
| Event | When |
| First Quarter 2020 Financial Results reporting* | April 23, 2020 |
| Annual General Meeting of Shareholders | May 13, 2020 |
| Half-Year 2020 Financial Results reporting* | July 23, 2020 |
| Nine-months 2020 Financial Results reporting* | October 22, 2020 |
*We will be in a silent period for 10 days ahead of the financial reporting.
Shareprice
Contact
Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil
Switzerland
- +41 58 844 00 00
- Contact us online
- How to get to us